UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039217
Receipt number R000044726
Scientific Title Investigation of the effects of 4-week ingestion of the development code GIC food
Date of disclosure of the study information 2020/02/07
Last modified on 2020/06/29 15:41:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of the effects of 4-week ingestion of the development code GIC food

Acronym

Investigation of the effects of 4-week ingestion of the development code GIC food

Scientific Title

Investigation of the effects of 4-week ingestion of the development code GIC food

Scientific Title:Acronym

Investigation of the effects of 4-week ingestion of the development code GIC food

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of GIC (development code) food ingestion effects in healthy males with a little lower lipid and glucose metabolism

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluation of the effects of 4-week intake of GIC (development code) food on lipid and glucose metabolism, skin condition, body temperature, and so on.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

In healthy males aged 20 to 59 years with a little lower lipid and glucose metabolism, daily ingestion of three GIC (development code) food capsules in a day (two capsules after lunch, one capsule after dinner) for 4 weeks.

Interventions/Control_2

In healthy males aged 20 to 59 years with a little lower lipid and glucose metabolism, daily ingestion of three placebo food capsules in a day (two capsules after lunch, one capsule after dinner) for 4 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

59 years-old >=

Gender

Male

Key inclusion criteria

-Healthy males
1.Subjects with a little higher BMI.
2.Subjects with a little higher fasting blood glucose.
3.Subjects who have a drinking habit.
4.Subjects who have a smoking habit.
5.Subjects with chronic insufficient sleep.

Key exclusion criteria

-Subjects taking GIC (development code) analog on a daily basis.
-Subjects with allergy or hypersensitivity to GIC (development code).
-Subjects with systemic illness.
-Subjects with a anamnesis of seizures based on nervous system disorders.
-Subjects who regularly take medicine.
-Subjects who has changed body weight more than +/- 3kg during 3 months before the test.
-Subjects with skin diseases on their face.
-Subjects undergoing beauty treatment (chemical peeling, laser treatment, etc.).
-Subjects who do not agree not to change their usual cosmetics during the test period.

Target sample size

24


Research contact person

Name of lead principal investigator

1st name Junko
Middle name
Last name Ishikawa

Organization

Kao Corporation

Division name

Biological Science Research

Zip code

321-3497

Address

2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN

TEL

+81-285-68-7888

Email

ishikawa.junko1@kao.com


Public contact

Name of contact person

1st name Masafumi
Middle name
Last name Aoki

Organization

Kao Corporation

Division name

Biological Science Research

Zip code

321-3497

Address

2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN

TEL

+81-285-68-7522

Homepage URL


Email

aoki.masafumi@kao.com


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Human Research Ethics Committee, Kao Corporation

Address

2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN

Tel

+81-3-5630-7263

Email

morisaki.naoko@kao.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

花王株式会社(栃木県)


Other administrative information

Date of disclosure of the study information

2020 Year 02 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

24

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2020 Year 01 Month 10 Day

Date of IRB

2020 Year 01 Month 10 Day

Anticipated trial start date

2020 Year 01 Month 24 Day

Last follow-up date

2020 Year 05 Month 15 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 01 Month 21 Day

Last modified on

2020 Year 06 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044726


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name